DEEP BRAIN STIMULATION DEVICES MARKET ANALYSIS

Regional Analysis

To learn more about this report, Request sample copy

North America Deep Brain Stimulation Devices Market Insights

North America dominates the deep brain stimulation devices market with an estimated share of 38.4% in 2024. This can be attributed to factors such as the presence of major industry players, availability of reimbursements, growing aging population susceptible to neurological disorders, and technical advancements. Companies like Medtronic, Boston Scientific, and Abbott have established a significant presence in the region and continue to invest in developing innovative technologies.

Asia Pacific Deep Brain Stimulation Devices Market Insights

The Asia Pacific region exhibits the fastest growth with an estimated share of 27.7% in 2024 and is expected to rise at a considerable rate over the forecast period. This can be credited to the improving healthcare infrastructure, increasing medical tourism, growing prevalence of neurological disorders due to changing lifestyle habits, rising disposable incomes, and supportive government policies focused on strengthening the medical devices industry across countries in the region.

Deep Brain Stimulation Devices Market Outlook for Key Countries

U.S. Deep Brain Stimulation Devices Market Insights

The U.S. deep brain stimulation devices market is anticipated to lead globally during the forecast period, driven by the rising prevalence of neurological disorders such as Parkinson's disease, dystonia, and essential tremors, along with an increasing number of clinical trials targeting psychiatric disorders. Technological advancements in DBS, including improved lead designs, implantable pulse generators, and remote monitoring capabilities, are enhancing the therapy's effectiveness and safety in the U.S. According to a 2022 Parkinson’s Foundation study, approximately one million individuals in the U.S. are living with Parkinson's disease, a number projected to rise to nearly 1.2 million by 2030. However, the high cost of DBS therapy, coupled with the complexity and potential risks associated with DBS implantation, is expected to pose challenges to the growth of the deep brain stimulation devices, deep brain stimulation devices market in the U.S.

Japan Deep Brain Stimulation Devices Market Insights

The deep brain stimulation devices market in Japan is experiencing substantial growth, fueled by the rising demand for innovative treatments for neurological disorders. DBS is approved in Japan for treating Parkinson's disease, and the market has shown steady expansion in recent years. The increasing prevalence of neurological disorders, driven by the country's aging population, has significantly boosted the demand for DBS devices. According to data published by the WHO in 2020, Parkinson's disease accounted for approximately 14,007 deaths in Japan, representing 1.27% of total deaths. Additionally, government-led initiatives to support the development and adoption of DBS technologies are expected to further drive the market growth during the forecast period.

Germany Deep Brain Stimulation Devices Market Insights

Germany's robust healthcare system supports the demand for deep brain stimulation devices, with significant investments in medical technology. Boston Scientific Corporation has received Ce Mark and launched the fourth-generation vercise genus deep brain stimulation (DBS) system in Germany. The system, featuring full-body MRI compatibility and Bluetooth capabilities, is designed to treat Parkinson's disease, essential tremor, and dystonia through precise brain stimulation for optimal symptom relief.

U.K. Deep Brain Stimulation Devices Market Insights

The U.K.'s National Health Service (NHS) has been integrating advanced deep brain stimulation technologies to address neurological disorders. In November 2022, the NHS adopted new DBS systems with enhanced MRI compatibility, improving treatment accessibility and patient safety. These developments highlight the global expansion and acceptance of DBS devices, driven by technological innovations and supportive healthcare policies.